Skip to main content
Enter your The Contraceptive Pipeline Database username.
Enter the password that accompanies your username.
FemBloc Permanent Contraceptive System
A degradable biopolymer is sent through a catheter-based delivery system placed in the uterus to permanently block the fallopian tubes after several weeks.
May 30, 2018
IDE approval granted by FDA in 2016 for U.S. prospective, multi-center clinical trial of FemBloc beginning in early 2017.
Does not require specialized surgical skills or investment in costly surgical equipment
Download Product Report